Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934773 · ClinicalTrials.gov registry record · NA

Post-Brain Injury Walking and Balance Recovery Program

A NA study, sponsored by The University of Texas Medical Branch, Galveston.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT05934773 is a NA study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05934773, a NA study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The purpose of this study is to test the efficacy of a walking and balance training program designed to safely challenge and improve walking performance and balance in relation to walking speed, strength, endurance, and balance after traumatic brain injury (TBI). The aim and primary hypothesis of this research project is: Aim) Test and implement a new personalized intervention strategy, in addition to usual and customary care at an inpatient rehabilitation clinic, to improve patient outcomes with secondary conditions associated with impaired balance and walking that typically occur post brain injury. After validation of the locomotor Battery of tests, we will implement a personalized training strategy for individuals based on their battery profile. Hypothesis) Individuals training with this individualized protocol will demonstrate improved walking and balance outcomes and those with lesser pre-intervention impairment will improve at a greater rate than those with greater pre-intervention impairment.

Interventions

  • DEVICE KineAssist robotic treadmill

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2022-08-18
Est. Completion 2025-04-04
Phase NA

What the Registry Record Tells You About NCT05934773

The ClinicalTrials.gov registry entry for NCT05934773 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which KineAssist robotic treadmill is the first listed.

NCT05934773 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05934773 about?

NCT05934773 is a clinical study titled "Post-Brain Injury Walking and Balance Recovery Program". The purpose of this study is to test the efficacy of a walking and balance training program designed to safely challenge and improve walking performance and balance in relation to walking speed, strength, endurance, and balance after traumatic brain injury (TBI). The aim and primary hypothesis of t...

What is the current status of trial NCT05934773?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-08-18. Estimated completion is 2025-04-04.

What interventions are being tested in trial NCT05934773?

The interventions under investigation include: KineAssist robotic treadmill (DEVICE).

Who is sponsoring clinical trial NCT05934773?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.